首页 | 本学科首页   官方微博 | 高级检索  
     


A Size‐Selective Intracellular Delivery Platform
Authors:May Tun Saung  Armon Sharei  Viktor A. Adalsteinsson  Nahyun Cho  Tushar Kamath  Camilo Ruiz  Jesse Kirkpatrick  Nehal Patel  Mari Mino‐Kenudson  Robert Langer  Klavs F. Jensen  Andrew S. Liss  J. Christopher Love
Affiliation:1. Department of Chemical Engineering, Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA, USA;2. Hospital Medicine Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA;3. Advanced Tissue Resources Core, Massachusetts General Hospital, Charlestown, MA, USA;4. Department of Pathology, Massachusetts General Hospital, Boston, MA, USA;5. Department of Surgery, Massachusetts General Hospital, Boston, MA, USA;6. The Broad Institute of Harvard and MIT, Cambridge, MA, USA
Abstract:Identifying and separating a subpopulation of cells from a heterogeneous mixture are essential elements of biological research. Current approaches require detailed knowledge of unique cell surface properties of the target cell population. A method is described that exploits size differences of cells to facilitate selective intracellular delivery using a high throughput microfluidic device. Cells traversing a constriction within this device undergo a transient disruption of the cell membrane that allows for cytoplasmic delivery of cargo. Unique constriction widths allow for optimization of delivery to cells of different sizes. For example, a 4 μm wide constriction is effective for delivery of cargo to primary human T‐cells that have an average diameter of 6.7 μm. In contrast, a 6 or 7 μm wide constriction is best for large pancreatic cancer cell lines BxPc3 (10.8 μm) and PANC‐1 (12.3 μm). These small differences in cell diameter are sufficient to allow for selective delivery of cargo to pancreatic cancer cells within a heterogeneous mixture containing T‐cells. The application of this approach is demonstrated by selectively delivering dextran‐conjugated fluorophores to circulating tumor cells in patient blood allowing for their subsequent isolation and genomic characterization.
Keywords:circulating tumor cells  intracellular delivery  microfluidics  size‐selective delivery
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号